1999
DOI: 10.1001/archinte.159.11.1248
|View full text |Cite
|
Sign up to set email alerts
|

A Metaregression Analysis of the Dose-Response Effect of Aspirin on Stroke

Abstract: Aspirin reduces the risk of stroke by approximately 15%, and this effect is uniform across aspirin doses from 50 to 1500 mg/d. The lowest effective aspirin dose has not yet been identified, but it could be lower than 50 mg/d.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1

Citation Types

3
90
0
6

Year Published

2000
2000
2019
2019

Publication Types

Select...
9

Relationship

0
9

Authors

Journals

citations
Cited by 180 publications
(101 citation statements)
references
References 24 publications
3
90
0
6
Order By: Relevance
“…78-9). [205][206][207][208][209][210] It was assumed that the fatality rates associated with MI were, for men, 35% for ages 55-64 years and 48%, 69% and 82% for age bands 65-74 years, 75-84 years and 85 years and older, respectively; and for women, 31%, 55%, 77% and 90%, respectively. These values were calculated by the authors from data reported by Volmink and colleagues.…”
Section: Risks Of MImentioning
confidence: 99%
See 1 more Smart Citation
“…78-9). [205][206][207][208][209][210] It was assumed that the fatality rates associated with MI were, for men, 35% for ages 55-64 years and 48%, 69% and 82% for age bands 65-74 years, 75-84 years and 85 years and older, respectively; and for women, 31%, 55%, 77% and 90%, respectively. These values were calculated by the authors from data reported by Volmink and colleagues.…”
Section: Risks Of MImentioning
confidence: 99%
“…205 After this period it was assumed that efficacy fell to a 15% relative risk reduction (95% CI 6 to 33%). 206 Patients already taking aspirin at the time of the TIA were assumed to have a constant 15% risk reduction of stroke throughout the duration of the model. The impact of aspirin on MI was assumed to be constant at 27% (95% CI 12 to 39%), calculated using data for combined antiplatelet therapy from the Antithrombotic Trialists' Collaboration trial.…”
Section: Assumed Efficacy Of Aspirinmentioning
confidence: 99%
“…Although there is no evidence from meta-analyses of aspirin trials to suggest that effectiveness decreases with dose, there remains uncertainty about whether doses <75 mg are as effective as daily doses ≥ 75 mg. 15 In particular, experts disagree about the optimal aspirin dose in preventing stroke. 74 Johnson and colleagues 74 conducted a metaregression analysis of RCTs in patients with previous TIA or stroke. They concluded that the effect of aspirin on stroke is uniform across aspirin doses from 50 to 1500 mg/day.…”
Section: The Aspirin Doses Were Different In the Two Trialsmentioning
confidence: 99%
“…2,3) On the other hand, depression is the major co-morbid disorders in CI sequelae. Selective serotonin reuptake inhibitors (SSRI) are the major antidepressants used to treat depression.…”
mentioning
confidence: 99%